![Michael Conway](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Conway
Corporate Officer/Principal bij METAGENOMI, INC.
Profiel
Michael Conway is currently the Vice President-Finance at Metagenomi, Inc. He previously worked as the Senior Director-Financial Planning & Analysis at Adamas Pharmaceuticals, Inc. from 2020 to 2021.
Before that, he was the Vice President-Finance at Metagenomi Technologies LLC.
Mr. Conway received his undergraduate degree from the University of Notre Dame and his MBA from the University of Michigan.
Actieve functies van Michael Conway
Bedrijven | Functie | Begin |
---|---|---|
METAGENOMI, INC. | Corporate Officer/Principal | 01-03-2022 |
Eerdere bekende functies van Michael Conway
Bedrijven | Functie | Einde |
---|---|---|
Adamas Pharmaceuticals, Inc. | Corporate Officer/Principal | 01-12-2021 |
Metagenomi Technologies LLC
![]() Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Opleiding van Michael Conway
University of Notre Dame | Undergraduate Degree |
University of Michigan | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
METAGENOMI, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Metagenomi Technologies LLC
![]() Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
Adamas Pharmaceuticals, Inc. |